Jian Ding

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Transcription Factor

Histone Deacetylase

Chronic Myeloid Leukemia

Top Venues

Signal transduction and targeted therapy

Cancer research

Cell death and differentiation

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Zhang, Zilu Pan, Jing Gao, Qingqing Wu, Gang Bai, Yan Li, Linjiang Tong, Fang Feng, Mengzhen Lai, Yingqiang Liu, Peiran Song, Yi Ning, Haotian Tang, Wen Luo, Yi Chen, Yan Fang, Hui Zhang, Qiupei Liu, Yudi Zhang, Hua Wang, Zhiwei Chen, Yi Chen, Meiyu Geng, Hongbin Ji, Guilong Zhao, Hu Zhou, Jian Ding, Hua Xie
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation. Signal transduction and targeted therapy 9 (1) (2024)
Xiameng Gai, Yingluo Liu, Xiaojing Lan, Luoyi Chen, Tao Yuan, Jun Xu, Yize Li, Ying Zheng, Yiyang Yan, Liya Yang, Yixian Fu, Shuai Tang, Siyuwei Cao, Xiaoyang Dai, Hong Zhu, Meiyu Geng, Jian Ding, Congying Pu, Min Huang
Oncogenic KRAS Induces Arginine Auxotrophy and Confers a Therapeutic Vulnerability to SLC7A1 Inhibition in Non-Small Cell Lung Cancer. Cancer research 84 (12) (2024)
Tao Zhang, Zilu Pan, Jing Gao, Qingqing Wu, Gang Bai, Yan Li, Linjiang Tong, Fang Feng, Mengzhen Lai, Yingqiang Liu, Peiran Song, Yi Ning, Haotian Tang, Wen Luo, Yi Chen, Yan Fang, Hui Zhang, Qiupei Liu, Yudi Zhang, Hua Wang, Zhiwei Chen, Yi Chen, Meiyu Geng, Hongbin Ji, Guilong Zhao, Hu Zhou, Jian Ding, Hua Xie
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation. Signal transduction and targeted therapy 9 (1) (2024)
Tao Zhang, Zilu Pan, Jing Gao, Qingqing Wu, Gang Bai, Yan Li, Linjiang Tong, Fang Feng, Mengzhen Lai, Yingqiang Liu, Peiran Song, Yi Ning, Haotian Tang, Wen Luo, Yi Chen, Yan Fang, Hui Zhang, Qiupei Liu, Yudi Zhang, Hua Wang, Zhiwei Chen, Yi Chen, Meiyu Geng, Hongbin Ji, Guilong Zhao, Hu Zhou, Jian Ding, Hua Xie
Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation. Signal transduction and targeted therapy 9 (1) (2024)
Xiameng Gai, Yingluo Liu, Xiaojing Lan, Luoyi Chen, Tao Yuan, Jun Xu, Yize Li, Ying Zheng, Yiyang Yan, Liya Yang, Yixian Fu, Shuai Tang, Siyuwei Cao, Xiaoyang Dai, Hong Zhu, Meiyu Geng, Jian Ding, Congying Pu, Min Huang
Oncogenic KRAS induces arginine auxotrophy and confers a therapeutic vulnerability to SLC7A1 inhibition in non-small cell lung cancer. Cancer research (2024)
Ji Zhou, Xu-Chao Zhang, Shan Xue, Mengdi Dai, Yueliang Wang, Xia Peng, Jianjiao Chen, Xinyi Wang, Yanyan Shen, Hui Qin, Bi Chen, Yu Zheng, Xiwen Gao, Zuoquan Xie, Jian Ding, Handong Jiang, Yi-Long Wu, Meiyu Geng, Jing Ai
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer. Signal transduction and targeted therapy 8 (1) (2023)
Zonglong Hu, Fan Wei, Yi Su, Yafang Wang, Yanyan Shen, Yanfen Fang, Jian Ding, Yi Chen
Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. Signal transduction and targeted therapy 8 (1) (2023)
Zonglong Hu, Fan Wei, Yi Su, Yafang Wang, Yanyan Shen, Yanfen Fang, Jian Ding, Yi Chen
Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. Signal transduction and targeted therapy 8 (1) (2023)
Zonglong Hu, Fan Wei, Yi Su, Yafang Wang, Yanyan Shen, Yanfen Fang, Jian Ding, Yi Chen
Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. Signal transduction and targeted therapy 8 (1) (2023)
Zonglong Hu, Fan Wei, Yi Su, Yafang Wang, Yanyan Shen, Yanfen Fang, Jian Ding, Yi Chen
Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. Signal transduction and targeted therapy 8 (1) (2023)
Ji Zhou, Xu-Chao Zhang, Shan Xue, Mengdi Dai, Yueliang Wang, Xia Peng, Jianjiao Chen, Xinyi Wang, Yanyan Shen, Hui Qin, Bi Chen, Yu Zheng, Xiwen Gao, Zuoquan Xie, Jian Ding, Handong Jiang, Yi-Long Wu, Meiyu Geng, Jing Ai
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer. Signal transduction and targeted therapy 8 (1) (2023)
Zonglong Hu, Fan Wei, Yi Su, Yafang Wang, Yanyan Shen, Yanfen Fang, Jian Ding, Yi Chen
Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. Signal transduction and targeted therapy 8 (1) (2023)
Xu Zhang, Yu-Xiang Wang, Xi Zhang, Yanyan Shen, Kang Yang, Qingyang Ma, Yuemei Qiao, Jiajie Shi, Yi Wang, Lan Xu, Biyu Yang, GaoXiang Ge, Landian Hu, Xiangyin Kong, Chunhao Yang, Yi Chen, Jian Ding, Ling-Hua Meng
Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors. Signal transduction and targeted therapy 8 (1) (2023)
Zonglong Hu, Fan Wei, Yi Su, Yafang Wang, Yanyan Shen, Yanfen Fang, Jian Ding, Yi Chen
Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. Signal transduction and targeted therapy 8 (1) (2023)
Ji Zhou, Xu-Chao Zhang, Shan Xue, Mengdi Dai, Yueliang Wang, Xia Peng, Jianjiao Chen, Xinyi Wang, Yanyan Shen, Hui Qin, Bi Chen, Yu Zheng, Xiwen Gao, Zuoquan Xie, Jian Ding, Handong Jiang, Yi-Long Wu, Meiyu Geng, Jing Ai
SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer. Signal transduction and targeted therapy 8 (1) (2023)
Zuoquan Xie, Zhen Wang, Fengying Fan, Jinpei Zhou, Zhaoxue Hu, Qingxia Wang, Xiyuan Wang, Qingzhong Zeng, Yan Zhang, Jiaxuan Qiu, Xiaoqian Zhou, Hui Xu, Hudagula Bai, Zhengsheng Zhan, Jian Ding, Huibin Zhang, Wenhu Duan, Xuekui Yu, Meiyu Geng
Structural insights into a shared mechanism of human STING activation by a potent agonist and an autoimmune disease-associated mutation. Cell discovery 8 (1) (2022)
Zuoquan Xie, Zhen Wang, Fengying Fan, Jinpei Zhou, Zhaoxue Hu, Qingxia Wang, Xiyuan Wang, Qingzhong Zeng, Yan Zhang, Jiaxuan Qiu, Xiaoqian Zhou, Hui Xu, Hudagula Bai, Zhengsheng Zhan, Jian Ding, Huibin Zhang, Wenhu Duan, Xuekui Yu, Meiyu Geng
Structural insights into a shared mechanism of human STING activation by a potent agonist and an autoimmune disease-associated mutation. Cell discovery 8 (1) (2022)
Yanran Deng, Dezhen Peng, Jing Xiao, Yunhe Zhao, Wenhao Ding, Shengtao Yuan, Li Sun, Jian Ding, Zizhang Zhou, Meixiao Zhan
Inhibition of the transcription factor ZNF281 by SUFU to suppress tumor cell migration. Cell death and differentiation (2022)